JOSEPH FRIDDLE: Open Payments
NPI 1487988838 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,076 in 120 payments from 20 companies in 2025. Trend: 2023 $2,531 · 2024 $2,784 · 2025 $2,076
Food & beverage: $2,076
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $420 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $301 |
| Otsuka America Pharmaceutical, Inc. | 18 | $270 |
| Axsome Therapeutics, Inc. | 10 | $176 |
| Lundbeck LLC | 8 | $164 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $128 |
| Alkermes, Inc. | 5 | $117 |
| Vanda Pharmaceuticals Inc. | 5 | $86 |
| Tris Pharma Inc | 3 | $68 |
| Noven Therapeutics, LLC | 3 | $61 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Auvelity, TRINTELLIX, HETLIOZ, Dyanavel XR, Xelstrym.
Industry payments across SC — which companies pay providers there.
